BRIEF published on 04/02/2026 at 09:54, 2 months 12 days ago Adage Capital Management crosses thresholds at DBV Technologies Voting Rights Crossing Thresholds DBV Technologies Subscription Vouchers Adage Capital Management
BRIEF published on 03/26/2026 at 22:24, 2 months 19 days ago DBV Technologies publishes its financial reports for 2025 AMF Financial Report DBV Technologies DRY VIASKIN®
BRIEF published on 03/26/2026 at 22:24, 2 months 19 days ago DBV Technologies Files 2025 Annual Report and Registration Document Financial Filing Annual Report Universal Registration Document Form 10-K DBV Technologies
PRESS RELEASE published on 03/26/2026 at 22:19, 2 months 19 days ago DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document DBV Technologies files 2025 Annual Report on Form 10-K and Universal Registration Document with SEC and AMF. Company developing treatments for food allergies Annual Report Immunotherapy Form 10-K DBV Technologies Food Allergies
BRIEF published on 03/24/2026 at 21:35, 2 months 21 days ago DBV Technologies joins the CAC Mid 60 and SBF 120 indices Euronext Paris SBF 120 DBV Technologies CAC Mid 60 Inclusion Indices
BRIEF published on 03/24/2026 at 21:35, 2 months 21 days ago DBV Technologies Joins CAC Mid 60 and SBF 120 Indices Biopharmaceutical SBF 120 DBV Technologies CAC Mid 60 VIASKIN®
PRESS RELEASE published on 03/24/2026 at 21:30, 2 months 21 days ago DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review DBV Technologies joins CAC Mid 60 and SBF 120 indices on Euronext Paris, increasing visibility among investors. Company focuses on food allergy treatments using VIASKIN patch technology Euronext Paris SBF 120 DBV Technologies Food Allergies CAC Mid 60
BRIEF published on 03/04/2026 at 22:35, 3 months 10 days ago DBV Technologies Announces Participation in March Investor Conferences Investor Conferences Biopharmaceutical DBV Technologies Food Allergies VIASKIN Patch
BRIEF published on 03/04/2026 at 22:35, 3 months 10 days ago DBV Technologies will participate in investor conferences in March Investor Conferences Biopharmaceutical DBV Technologies March 2026 Citizens Life Sciences
PRESS RELEASE published on 03/04/2026 at 22:30, 3 months 10 days ago DBV Technologies to Participate in Upcoming March Investor Conferences DBV Technologies to participate in upcoming investor conferences to present its late-stage biopharmaceutical developments for food allergies. Company uses proprietary VIASKIN patch technology for treatment Investor Conferences Biopharmaceutical DBV Technologies Food Allergies VIASKIN Patch
Published on 06/13/2026 at 04:50, 1 day 20 hours ago BTU Additional Details Regarding Recent Acquisition
Published on 06/13/2026 at 02:00, 1 day 23 hours ago Battery X Metals Appoints Automotive Industry Professional from Canadian Subsidiary of One of the World's Leading Premium Automobile Manufacturers, Headquartered in Munich, Germany, to its Advisory Board to Advance Commercialization of Its Patent-Pending
Published on 06/12/2026 at 23:15, 2 days 2 hours ago BioNxt Announces Non-Brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
Published on 06/12/2026 at 22:30, 2 days 3 hours ago Fox River Provides Reminder To Vote And Updated Dissent Rights
Published on 06/12/2026 at 15:14, 2 days 10 hours ago Reeflex Solutions Inc. Reports Voting Results From Annual and Special Meeting of Shareholders
Published on 06/14/2026 at 14:50, 10 hours 48 minutes ago Zug voters say yes to Metalli development plan
Published on 06/14/2026 at 13:30, 12 hours 8 minutes ago Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress
Published on 06/14/2026 at 10:42, 14 hours 56 minutes ago LightOn Demonstrates the Flexibility of Its OCR Model by Adapting It to Arabic Through Targeted Training.
Published on 06/13/2026 at 08:18, 1 day 17 hours ago EQS-Adhoc: AT&S Austria Technologie & Systemtechnik AG: AT&S expands AI substrate capacity in Kulim and increases outlook for 2026/27
Published on 06/13/2026 at 01:05, 2 days ago OpenText to Create 400 Jobs with €105 Million Investment in Cork and Galway to Expand Agentic AI and Sovereign Cloud in Europe
Published on 06/12/2026 at 09:00, 2 days 16 hours ago Pricing of Green Senior Secured Notes due 2031 by Neoen FINCO PLC
Published on 06/11/2026 at 17:45, 3 days 7 hours ago BAIKOWSKI: Annual General Meeting of June 11, 2026 - Dividend of €0.30 per share, to be paid out on June 30, 2026
